Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank42
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P42
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-58.30%
2024-168.26%
2023340.01%
202230.94%
2021-368.84%
2020152.99%
201943.27%
2018-26.76%
2017-74.01%
2016-103.91%